Company: FORL
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045609
Chunk: 48

Company: Four Leaf Acquisition Corp
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
 a 30-days cure period for breaches that are curable), provided that such right to terminate will not be available to either party if it has breached in any material respect its obligations set forth in the Merger Agreement;

    (iv)
    by either the Company or Xiaoyu Dida if any Order (as defined in the Merger Agreement) having the effect of prohibiting or preventing the consummation of the Closing shall be in effect and shall have become final and non-appealable; provided, however, that the right to terminate this shall not be available to a party if such Order was due to such party’s breach of or failure to perform any of its representations, warranties, covenants or agreements set forth in the Merger Agreement;

26

    (v)
    by either the Company or Xiaoyu Dida if the CSRC Filing Notice has not been obtained by the Outside Date;

    (vi)
    by either Company or Xiaoyu Dida if Company stockholder approval shall not have been obtained by reason of the failure to obtain the required vote upon a vote held at the special meeting or any adjournment or postponement thereof; or

    (vii)
    by the Company if Xiaoyu Dida shareholder approval shall not have been obtained by reason of the failure to obtain the required vote at the general meeting duly convened therefor or at any adjournment or postponement thereof.

If the Merger Agreement
is validly terminated, none of the parties to the Merger Agreement will have any liability or further obligation under the Merger Agreement.

Our sponsor is ALWA Sponsor
LLC (the “Sponsor”), a Delaware limited liability company.

The registration statement
for the Company’s initial public offering (“IPO”) was declared effective on March 16, 2023. On March 16, 2023, the Company
consummated its IPO of 5,200,000 units (“Units”). On March 17, 2023, the underwriters partially exercised their over-allotment
option and purchased 221,000 additional Units. Each Unit consists of one share of Class A common stock, $0.0001 par value per share (“Class
A common stock” or “Public Shares”), and one redeemable warrant exercisable into one share of Class A common stock at
an exercise price of $11.50 per share (“Public Warrant”). The Units were sold at an offering price of $10.00 per Unit, generating